In July, we asked our visitors for their opinions regarding the potential for patient recruitment across different regions of the world. About half the participants in our survey (49%) declared they see the largest potential in Central and Eastern Europe (CEE). Almost tied in second and third place, our respondents chose the Asia-Pacific region (26.5%) and Latin America (24.5%).
It is no surprise that CEE is the region with the highest perceived potential. The closeness of the region to Western Europe (a hub for pharma Research & Development), a clear regulatory environment, coupled with a fairly developed health infrastructure and a highly educated healthcare force makes the region an interesting place to conduct clinical trials.
On the other hand, while the Asia-Pacific region and Latin America are attractive in terms of population, both markets face daunting challenges for the recruitment of patients for a number of reasons, including a lack of specialized medical infrastructure and an insufficient legal framework that protects both patients and intellectual property.
Stay tuned for the Question of the Month in September!
Results #KCR_QoM from previous months:
March 2018 - Consolidation in the CRO industry makes my work...
Associate Director, PR & Marketing
mobile: (+48) 605 053 164